During the past decade, Bellflower Dialysis Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Bellflower Dialysis Center" are "Chronic Renal Failure Requiring Hemodialysis" (2 trials). Many other conditions were trialed in "Bellflower Dialysis Center" in a lesser frequency.

Most popular intervention types in "Bellflower Dialysis Center" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Epoetin Hospira" (2 trials). Other intervention names were less common.

The vast majority of trials in "Bellflower Dialysis Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Bellflower Dialysis Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Bellflower Dialysis Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bellflower Dialysis Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".